ZOETIS INC. |
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
| 159,2 EUR | -0,13% |
|
+1,69% | -10,22% |
Attività
- animali domestici (64,4%): cani e gatti (94,9% delle vendite nette) e cavalli (5,1%);
- bestiame (34,5%): bovini (51,6% delle vendite), suini (20,2%), pollame (17,1%), pesci (7,6%) e altro (3,5%);
- altro (1,1%).
Le vendite nette si suddividono per famiglia di prodotti in parassiticidi (23%), vaccini (21,3%), prodotti dermatologici (16,4%), antinfettivi (13,4%), additivi alimentari medici (4,5%), prodotti diagnostici (4,4%) e altro (17%).
Alla fine del 2022, il Gruppo avrà 29 siti di produzione in tutto il mondo.
Gli Stati Uniti rappresentano il 53,4% delle vendite nette.
Numero di dipendenti: 14 100
Vendite per attività
| USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Parasiticides
22,8
%
| 1 860 | 23,0 % | 1 947 | 22,8 % | +4,68% |
Vaccines
20,7
%
| 1 718 | 21,3 % | 1 771 | 20,7 % | +3,08% |
Dermatology
16,7
%
| 1 329 | 16,4 % | 1 427 | 16,7 % | +7,37% |
Other Pharmaceuticals
15,0
%
| 1 043 | 12,9 % | 1 280 | 15,0 % | +22,72% |
Anti-infectives
12,4
%
| 1 081 | 13,4 % | 1 057 | 12,4 % | -2,22% |
Animal Health Diagnostics
4,4
%
| 353 | 4,4 % | 376 | 4,4 % | +6,52% |
Medicated Feed Additives
4,1
%
| 360 | 4,5 % | 354 | 4,1 % | -1,67% |
Other Non-pharmaceuticals
3,0
%
| 250 | 3,1 % | 254 | 3,0 % | +1,60% |
Contract Manufacturing and Human Health
0,9
%
| 86 | 1,1 % | 78 | 0,9 % | -9,30% |
Vendite per regione
| USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
United States
53,3
%
| 4 313 | 53,4 % | 4 555 | 53,3 % | +5,61% |
Other Emerging Markets
9,2
%
| 758 | 9,4 % | 784 | 9,2 % | +3,43% |
Other Developed Markets
6,0
%
| 468 | 5,8 % | 512 | 6,0 % | +9,40% |
Brazil
4,6
%
| 330 | 4,1 % | 393 | 4,6 % | +19,09% |
Australia
3,8
%
| 289 | 3,6 % | 323 | 3,8 % | +11,76% |
China
3,7
%
| 382 | 4,7 % | 320 | 3,7 % | -16,23% |
United Kingdom
3,2
%
| 235 | 2,9 % | 277 | 3,2 % | +17,87% |
Canada
3,0
%
| 238 | 2,9 % | 255 | 3,0 % | +7,14% |
Germany
2,4
%
| 176 | 2,2 % | 202 | 2,4 % | +14,77% |
Mexico
1,9
%
| 136 | 1,7 % | 162 | 1,9 % | +19,12% |
Japan
1,8
%
| 173 | 2,1 % | 158 | 1,8 % | -8,67% |
France
1,7
%
| 126 | 1,6 % | 142 | 1,7 % | +12,70% |
Chile
1,6
%
| 141 | 1,7 % | 140 | 1,6 % | -0,71% |
Spain
1,4
%
| 118 | 1,5 % | 122 | 1,4 % | +3,39% |
Italy
1,4
%
| 111 | 1,4 % | 121 | 1,4 % | +9,01% |
Global
0,9
%
| 86 | 1,1 % | 78 | 0,9 % | -9,30% |
Dirigenti
| Dirigenti | Titolo | Età | Da |
|---|---|---|---|
Kristin Peck
CEO | Chief Executive Officer | 52 | 01/01/12 |
Wetteny Joseph
DFI | Director of Finance/CFO | 52 | 01/06/21 |
Mike McFarland
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/11 |
Robert Polzer
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/01/15 |
Wafaa Mamilli
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/01/20 |
Steven Frank
IRC | Investor Relations Contact | - | 01/03/15 |
William Dorsey
PRN | Corporate Officer/Principal | - | - |
Ester Banque
PRN | Corporate Officer/Principal | - | 10/07/23 |
Abhay Nayak
PRN | Corporate Officer/Principal | - | - |
Roxanne Lagano
HRO | Human Resources Officer | 59 | 01/10/12 |
Amministratori
| Amministratori | Titolo | Età | Da |
|---|---|---|---|
| Chairman | 71 | 01/01/13 | |
Louise Parent
BRD | Director/Board Member | 73 | 01/08/13 |
Robert Scully
BRD | Director/Board Member | 74 | 01/06/13 |
Kristin Peck
CEO | Chief Executive Officer | 52 | 01/01/12 |
Paul Bisaro
BRD | Director/Board Member | 63 | 01/05/15 |
Frank D'Amelio
BRD | Director/Board Member | 66 | 01/07/12 |
Sanjay Khosla
BRD | Director/Board Member | 71 | 01/06/13 |
Gregory Norden
BRD | Director/Board Member | 66 | 01/01/13 |
| Director/Board Member | 55 | 25/07/22 | |
Willie Reed
BRD | Director/Board Member | 69 | 04/03/14 |
Classe di azioni
| Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
|---|---|---|---|---|---|
| Azione A | 1 | 501 239 175 | 455 190 400 ( 90,81 %) | 44 944 038 ( 8,967 %) | 90,81 % |
Coordinate società
Società del gruppo
| Nome | Categoria e settore |
|---|---|
Zoetis Treasury Center BV
| |
Zoetis Ceská republika sro
 Zoetis Ceská republika sro BiotechnologyHealth Technology Part of Zoetis, Inc., Zoetis Ceská republika sro is a company located in Czechia that specializes in researching, developing, manufacturing, and marketing medicines and vaccines for animals. |
Biotechnology
|
Zoetis Korea Ltd.
 Zoetis Korea Ltd. Pharmaceuticals: MajorHealth Technology Part of Zoetis, Inc., Zoetis Korea Ltd. is a South Korean company that manufactures veterinary medicinal preparations. The company is located in South Korea. |
Pharmaceuticals: Major
|
Zoetis Philippines, Inc.
| |
Pharmaq Vietnam Co. Ltd.
| |
Zoetis Pharmaceutical Research Pvt Ltd.
| |
Zoetis Vietnam LLC
 Zoetis Vietnam LLC Pharmaceuticals: MajorHealth Technology Zoetis Vietnam LLC engages in the distribution of medicine and vaccinations for pets and livestocks. The company was founded on August 16, 2013 and is headquartered in Ho Chi Minh City, Vietnam. |
Pharmaceuticals: Major
|
Zoetis Singapore Pte Ltd.
| |
Zoetis India Ltd.
 Zoetis India Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2007, Zoetis India Ltd. is a subsidiary of Zoetis, Inc. that manufactures vaccines and injectable biologic medicines. The company is based in Mumbai, India. |
Pharmaceuticals: Major
|
Settore
Vendite per attività
Vendite per regione
Rating Trading
Rating Investimento
ESG Refinitiv
Vendita
Buy
Raccomandazione media
Buy
Numero di analisti
17
Ultimo prezzo di chiusura
172,8
USD
Prezzo obiettivo medio
211,2
USD
Differenza / Target Medio
+22,23%
Revisioni EPS
| Variaz. 1 gen. | Capi. | |
|---|---|---|
| +12,08% | 8,4 Mrd | |
| +25,88% | 3,76 Mrd | |
| -0,14% | 3,18 Mrd | |
| +14,19% | 1,67 Mrd | |
| +0,56% | 1,64 Mrd | |
| -17,79% | 1,38 Mrd | |
| -0,39% | 1,32 Mrd | |
| -5,20% | 1,24 Mrd | |
| +6,40% | 1,12 Mrd |
- Borsa valori
- Azioni
- Azione ZTS
- Azione ZOE
- Società Zoetis Inc.